...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Prescribing Pattern of Medications that induce Extra Pyramidal Symptoms and Weight Gain in Psychotic Patients
【24h】

Prescribing Pattern of Medications that induce Extra Pyramidal Symptoms and Weight Gain in Psychotic Patients

机译:引起精神病患者锥体外系症状和体重增加的药物处方模式

获取原文
           

摘要

The objective of the study is to assess the prescribing pattern of drugs that induces Extra Pyramidal Symptoms (EPS) and weight gainin psychotic patients under treatment. A descriptive-observational study was carried out in the psychiatry department of MVJmedical college and research hospital for a period of six months. A total of 105 in-patients were enrolled into the study afterfulfilling the study criteria and obtaining informed consent. The prescription pattern was analyzed and the various medicationrelated problems were identified. The obtained data were analyzed descriptively and statistically. A total of 105 psychotic patientswere enrolled into the study. On analyzing the prescription, most of the patients were prescribed with more than 3 drugs. Majorityof the patients were prescribed with 3 psychotropic drug (43.80%) in which antipsychotics were prescribed to all the patient. Themost commonly given combination of psychotropic drugs are antipsychotic- anti anxiety (42.85%). 70.48% of the study populationwas on antipsychotic mono therapy. Majority of the patients were taking only atypical antipsychotics (83.80%). Prescribing error(32.38%) was the commonly seen medication error followed by dispensing error. There were a total of 353 interactions identified,out of which 61 were major interactions. Our study showed that extra pyramidal symptoms and weight gain are still serious sideeffects of the treatment of various psychotic disorders. This is confounded by various factors like medication error, drug-druginteraction, poly pharmacy. The clinicians can be advised to compare the benefit risk ratio based on the needs of the individualpatients and thereby choosing an appropriate drug with optimum therapeutic efficacy and low toxic effect. The patients should beadvised to control their diet and to involve in physical activities when under treatment to control unnecessary weight gain.
机译:该研究的目的是评估在治疗中的精神病患者中诱发锥体外系症状(EPS)和体重增加的药物的处方模式。 MVJ医学院和研究医院的精神科进行了描述性观察研究,为期六个月。在满足研究标准并获得知情同意后,共有105名住院患者参加了研究。分析了处方模式,并确定了各种与药物有关的问题。对获得的数据进行描述性和统计性分析。总共105名精神病患者被纳入研究。在分析处方时,大多数患者都处方了3种以上的药物。多数患者开了3种精神药物(43.80%),其中对所有患者开了抗精神病药。最常用的精神药物组合是抗精神病抗焦虑药(42.85%)。研究人群的70.48%接受了抗精神病药物单一疗法。大多数患者仅服用非典型抗精神病药(83.80%)。处方错误(32.38%)是常见的用药错误,其次是配药错误。总共确定了353个交互,其中61个是主要交互。我们的研究表明,额外的锥体束症状和体重增加仍然是治疗各种精神病的严重副作用。这与药物错误,药物相互作用,多药房等各种因素混淆。可以建议临床医生根据各个患者的需求比较受益风险比率,从而选择具有最佳治疗效果和低毒作用的合适药物。建议患者在治疗期间控制饮食并进行体育锻炼,以控制不必要的体重增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号